Posted by SLS on October 22, 2013, at 5:39:56
In reply to Re: Cariprazine - A better Abilify?, posted by linkadge on October 21, 2013, at 17:23:02
Do you think that the D3 receptor in the nucleus accumbens makes a good target in treating schizophrenia? Negative symptoms only? It is important to recognize that D2 receptors in the striatum will still be antagonized. I don't know what the D3/D2 ratio in binding affinity is for cariprazine.
http://www.ncbi.nlm.nih.gov/pubmed/9473144
http://en.wikipedia.org/wiki/Cariprazine
http://www.ncbi.nlm.nih.gov/pubmed/?term=cariprazine+striatum
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1052699
URL: http://www.dr-bob.org/babble/20130930/msgs/1052756.html